In light of the above-mentioned findings andas a continuationof our studies, herein we aimed to evaluate the inhibition effectsof newly synthesized hydrazone derivatives (7–12) toward four metabolic enzymes (hCA I, hCA II, AChE, BChE),linked to various diseases, including AD. This evidence concerns the gene BCHE and Alzheimer disease.